Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction.

Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
AJP Heart and Circulatory Physiology (Impact Factor: 4.01). 06/2012; 303(5):H605-18. DOI: 10.1152/ajpheart.00366.2012
Source: PubMed

ABSTRACT Apelin is an endogenous ligand for the angiotensin-like 1 receptor (APJ) and has beneficial effects against myocardial ischemia-reperfusion injury. Little is known about the role of apelin in the homing of vascular progenitor cells (PCs) and cardiac functional recovery postmyocardial infarction (post-MI). The present study investigated whether apelin affects PC homing to the infarcted myocardium, thereby mediating repair and functional recovery post-MI. Mice were infarcted by coronary artery ligation, and apelin-13 (1 mg·kg(-1)·day(-1)) was injected for 3 days before MI and for 14 days post-MI. Homing of vascular PCs [CD133(+)/c-Kit(+)/Sca1(+), CD133(+)/stromal cell-derived factor (SDF)-1α(+), and CD133(+)/CXC chemokine receptor (CXCR)-4(+)] into the ischemic area was examined. Myocardial Akt, endothelial nitric oxide synthase (eNOS), VEGF, jagged1, notch3, SDF-1α, and CXCR-4 expression were assessed at 24 h and 14 days post-MI. Functional analyses were performed on day 14 post-MI. Mice that received apelin-13 treatment demonstrated upregulation of SDF-1α/CXCR-4 expression and dramatically increased the number of CD133(+)/c-Kit(+)/Sca1(+), CD133(+)/SDF-1α(+), and c-Kit(+)/CXCR-4(+) cells in infarcted hearts. Apelin-13 also significantly increased Akt and eNOS phosphorylation and upregulated VEGF, jagged1, and notch3 expression in ischemic hearts. This was accompanied by a significant reduction of myocardial apoptosis. Furthermore, treatment with apelin-13 promoted myocardial angiogenesis and attenuated cardiac fibrosis and hypertrophy together with a significant improvement of cardiac function at 14 days post-MI. Apelin-13 increases angiogenesis and improves cardiac repair post-MI by a mechanism involving the upregulation of SDF-1α/CXCR-4 and homing of vascular PCs.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: The migration and proliferation of bone marrow-derived mesenchymal stem cells (BMSC) is critical to treatment of ischemic injury. Apelin is a recently discovered vasoactive peptide, which has been demonstrated to be the endogenous ligand for the previously orphaned G protein-coupled receptor, angiotensin-like 1 receptor. Apelin has mitogenic effects on a wide variety of cell types. However, the effects of apelin on BMSC proliferation have not been evaluated. We hypothesize that the peptide apelin-13 may enhance BMSC proliferation. Rat BMSC obtain from the bone marrow of 3- to 4-month-old SD rats. There are novel data suggesting that apelin-13 significantly simulates BMSC proliferation and promotes the expression of p-AKT, p-GSK3β and cyclin D1 in a concentration-dependent manner. Apelin-13-induced the increases of p-AKT, p-GSK3β and cyclin D1 could be abolished by LY294002 (AKT inhibitor) which prevents apelin-13-induced BMSC proliferation. However, LiCl (GSK inhibitor) up-regulates the expression of p-GSK3β and cyclin D1, promotes BMSC proliferation, which enhances the proliferation effect of apelin-13 obviously. In conclusion, the AKT/GSK3β/cyclin D1 signaling pathway is involved in apelin-13-induced BMSC proliferation.
    International Journal of Peptide Research and Therapeutics 12/2014; 20(4). DOI:10.1007/s10989-014-9404-1 · 0.83 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Heart failure following myocardial infarction (MI) is the leading cause of death in diabetic patients. Angiogenesis contributes to cardiac repair and functional recovery in post-MI. Our previous study shows that apelin (APLN) increases Sirtuin 3 (Sirt3) expression and ameliorates diabetic cardiomyopathy. In this study, we further investigated the direct role of Sirt3 in APLN-induced angiogenesis in post-MI model of diabetes. Wild-type (WT) and Sirt3 knockout (Sirt3KO) mice were induced into diabetes by i.p. streptozotocin (STZ). STZ mice were then subjected to MI followed by immediate intramyocardial injection with adenovirus-apelin (Ad-APLN). Our studies showed that Sirt3 expression was significantly reduced in the hearts of STZ mice. Ad-APLN treatment resulted in up-regulation of Sirt3, angiopoietins/Tie-2 and VEGF/VEGFR2 expression together with increased myocardial vascular densities in WT-STZ+MI mice, but these alterations were not observed in Sirt3KO-STZ+MI mice. In vitro, overexpression of APLN increased Sirt3 expression and angiogenesis in endothelial progenitor cells (EPC) from WT mice, but not in EPC from Sirt3KO mice. APLN gene therapy increases angiogenesis and improves cardiac functional recovery in diabetic hearts via up-regulation of Sirt3 pathway.
    Journal of Cellular and Molecular Medicine 10/2014; 19(1). DOI:10.1111/jcmm.12453 · 3.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sirtuin-3 (Sirt3) has a critical role in the regulation of human aging and reactive oxygen species (ROS) formation. A recent study has identified Sirt3 as an essential regulator of stem cell aging. This study investigated whether Sirt3 is necessary for bone marrow cell (BMC)-mediated cardiac repair in post-myocardial infarction (MI). In vitro, BMC-derived endothelial progenitor cells (EPCs) from wild type (WT) and Sirt3KO mice were cultured. EPC angiogenesis, ROS formation and apoptosis were assessed. In vivo, WT and Sirt3 KO mice were subjected to MI and BMCs from WT and Sirt3 KO mice were injected into ischemic area immediately. The expression of VEGF and VEGFR2 was reduced in Sirt3KO-EPCs. Angiogenic capacities and colony formation were significantly impaired in Sirt3KO-EPCs compared to WT-EPCs. Loss of Sirt3 further enhanced ROS formation and apoptosis in EPCs. Overexpression of Sirt3 or treatment with NADPH oxidase inhibitor apocynin (Apo, 200 and 400 microM) rescued these abnormalities. In post-MI mice, BMC treatment increased number of Sca1+/c-kit+ cells; enhanced VEGF expression and angiogenesis whereas Sirt3KO-BMC treatment had little effects. BMC treatment also attenuated NADPH oxidase subunits p47phox and gp91phox expression, and significantly reduced ROS formation, apoptosis, fibrosis and hypertrophy in post-MI mice. Sirt3KO-BMC treatment did not display these beneficial effects. In contrast, Sirt3KO mice treated with BMCs from WT mice attenuated myocardial apoptosis, fibrosis and improved cardiac function. Our data demonstrate that Sirt3 is essential for BMC therapy; and loss of Sirt3 limits BMC-mediated angiogenesis and cardiac repair in post-MI.
    PLoS ONE 09/2014; 9(9):e107011. DOI:10.1371/journal.pone.0107011 · 3.53 Impact Factor
    This article is viewable in ResearchGate's enriched format


Available from
Dec 4, 2014